Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced the award of a grant totaling $4,143,652 from the National Institutes of Health (NIH) for Progenics’ program to develop novel monoclonal antibodies to treat Clostridium…
Tag: virus
Scientists develop first screening method to identify river blindness disease
The breakthrough will assist massive effort to eliminate the widespread tropical scourge Scientists from The Scripps Research Institute have developed the first screening method that rapidly identifies individuals with active river blindness,…
Research to focus effective use of artemisinin stocks for malaria
The frontline malaria treatment artemisinin could soon be treating more people for less cost, thanks to a research collaboration between Bradford and Shanghai. Artemisinin is the leading treatment on the market able…
Profectus BioSciences awarded $3.1M Fast Track SBIR grant to develop prophylactic vaccine against HIV
Profectus BioSciences, Inc., a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases, today announced the award of a Fast Track SBIR from the Division of AIDS,…
Ceremed awarded NIH SBIR grant to develop soluble carrier for topical delivery of antibiotic Vancomycin
Ceremed, Inc. was awarded a Small Business Innovation Research (SBIR) grant, the company’s third in a series of grants from the National Institutes of Health to develop a versatile soluble carrier with…
FDA awards $2.9 million to support tuberculosis research projects
The U.S. Food and Drug Administration today announced the award of $2.9 million to support six research projects that will help with the diagnosis, treatment, and prevention of tuberculosis (TB). TB remains…
$3.4M grant for study to distinguish bacterial infections from viral infections in infants with fevers
Octavio Ramilo, MD, chief of Infectious Diseases at Nationwide Children’s Hospital, is one of three principal investigators who will share in a five-year, $3.4 million grant from the Eunice Kennedy Shriver National…
Suspected hand, foot and mouth disease on Denver flight
Two children arrived on a flight from Mexico to Denver showing symptoms of the contagious illness called ‘hand, foot and mouth’ disease (HFMD) and were checked by paramedics. They were allowed to…
Hospitals told to come clean about their infection rates
NHS trusts will be forced to publish figures showing the number of cases suffering from a wide range of bugs, as part of efforts to help the public make an “informed choice”…
Herpevac Trial for Women finds experimental vaccine ineffective in prevention of genital herpes disease
An experimental vaccine intended to prevent genital herpes disease in women, although generally safe and well-tolerated, proved ineffective when tested in the recently concluded clinical study known as the Herpevac Trial for…
Achillion initiates ACH-1625 Phase II dosing for HCV infection
Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that the Company has initiated patient dosing in…
Albert Einstein College of Medicine receives grant to study role of proteins in health and disease
The National Institute of General Medical Sciences (NIGMS) has awarded Albert Einstein College of Medicine of Yeshiva University a five-year, $30 million grant to study the structure and function of thousands of…
Discovery on HIV patients’ immune defenses enables to design new vaccines
New discoveries about the immune defenses of rare HIV patients who produce antibodies that prevent infection suggest a novel direction for designing new vaccines. Researchers at Rockefeller University and colleagues have now…
Malaria vaccine development meeting begins in Washington
Agence France-Presse Reports on a malaria vaccine development meeting that kicks off Tuesday in Washington, D.C. “One of the stars at the meeting will be the RTS,S malaria vaccine, which has been…
MRSA survivors to share experience at World MRSA Day kickoff event
No one needs to explain to the people who have experienced it the danger posed by methicillin-resistant Staphylococcus aureus, the antibiotic-defying bacterium commonly known as MRSA. In 2005, about 94,360 people developed…